PHAR
Pharming Group

940
Mkt Cap
$1.29B
Volume
17,891.00
52W High
$19.05
52W Low
$7.50
PE Ratio
1,280.56
PHAR Fundamentals
Price
$18.44
Prev Close
$18.16
Open
$18.54
50D MA
$16.99
Beta
0.43
Avg. Volume
26,043.95
EPS (Annual)
-$0.1761
P/B
4.77
Loading...
Loading...
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Pharming Group N.V. - ADR?
What is the 52-week high for Pharming Group N.V. - ADR?
What is the 52-week low for Pharming Group N.V. - ADR?
What is Pharming Group N.V. - ADR stock price today?
What was Pharming Group N.V. - ADR stock price yesterday?
What is the PE ratio of Pharming Group N.V. - ADR?
What is the Price-to-Book ratio of Pharming Group N.V. - ADR?
What is the 50-day moving average of Pharming Group N.V. - ADR?

Latest PHAR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.